Zobrazeno 1 - 10
of 27
pro vyhledávání: '"D E Speiser"'
Autor:
Haifeng C. Xu, Alisha R. Elford, Philipp A. Lang, Dieter Häussinger, Michael Lohoff, David R. McIlwain, Aleksandra A. Pandyra, Tak W. Mak, D E Speiser, Stefanie Scheu, Sathish Kumar Maney, Melanie Grusdat, Magdalena Huber, Karl S. Lang, Elisabeth Lang, Vitaly I. Pozdeev, Sarah Q. Crome, Celine Robert-Tissot, Regine J. Dress, H-W Mittrücker, J Knievel, Pamela S. Ohashi, Johannes G. Bode, Sara R. Hamilton, Klaus Pfeffer
Publikováno v:
CELL DEATH AND DIFFERENTIATION
Cell Death and Differentiation, vol. 21, no. 7, pp. 1050-1060
Cell death and differentiation
Cell Death and Differentiation
Cell Death and Differentiation, vol. 21, no. 7, pp. 1050-1060
Cell death and differentiation
Cell Death and Differentiation
CD8(+) T cell functions are critical for preventing chronic viral infections by eliminating infected cells. For healthy immune responses beneficial destruction of infected cells must be balanced against immunopathology resulting from collateral damag
Autor:
D E Speiser, M F Bachmann, T W Frick, K McKall-Faienza, E Griffiths, K Pfeffer, T W Mak, P S Ohashi
Allogeneic bone marrow transplantation is frequently associated with graft-vs-host disease (GVHD). To understand the effector mechanisms of GVHD, we investigated the role of the TNF receptor p55 (TNFRp55), which is known to be important in inflammati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf84885be42f4ea81ad20393f62bb23
https://ora.ox.ac.uk/objects/uuid:f7c868bb-48bb-4c2f-917e-f83d9424cc2b
https://ora.ox.ac.uk/objects/uuid:f7c868bb-48bb-4c2f-917e-f83d9424cc2b
Autor:
P, Baumgaertner, C, Costa Nunes, A, Cachot, H, Maby-El Hajjami, L, Cagnon, M, Braun, L, Derré, J-P, Rivals, D, Rimoldi, S, Gnjatic, S, Abed Maillard, P, Marcos Mondéjar, M P, Protti, E, Romano, O, Michielin, P, Romero, D E, Speiser, C, Jandus
Publikováno v:
Oncoimmunology. 5(10)
Long synthetic peptides and CpG-containing oligodeoxynucleotides are promising components for cancer vaccines. In this phase I trial, 19 patients received a mean of 8 (range 1–12) monthly vaccines s.c. composed of the long synthetic NY-ESO-179–10
Autor:
M J, Pittet, D E, Speiser, D, Liénard, D, Valmori, P, Guillaume, V, Dutoit, D, Rimoldi, F, Lejeune, J C, Cerottini, P, Romero
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7
Peptide-based vaccines are currently being tested for their ability to induce or augment tumor antigen (Ag)-specific CD8+ T-cell responses in cancer patients. Here we report that the frequency of circulating CD8+ T cells directed against the Melan-A/
Autor:
D E, Speiser, M, Migliaccio, M J, Pittet, D, Valmori, D, Liénard, F, Lejeune, P, Reichenbach, P, Guillaume, I, Lüscher, J C, Cerottini, P, Romero
Publikováno v:
European journal of immunology. 31(2)
Cycling lymphocytes may express the enzyme telomerase which is involved in maintenance of telomere length and cell proliferation potential. In CD8(+) T cells freshly isolated from peripheral blood, we found that in vivo cycling cells expressed HLA-DR
Autor:
P, Romero, M J, Pittet, D, Valmori, D E, Speiser, V, Cerundolo, D, Liénard, F, Lejeune, J C, Cerottini
Publikováno v:
Ernst Schering Research Foundation workshop. (30)
Publikováno v:
European journal of immunology. 30(2)
Deletion of mature T cells maintains cellular homeostasis and is involved in the maintenance of self tolerance to some peripheral self antigens. Previous studies have presented conflicting evidence for a role of the tumor necrosis factor receptor (TN
Publikováno v:
European journal of immunology. 29(7)
Understanding the mechanisms of T cell activation versus induction of unresponsiveness is of critical importance for the rational modulation of immune responses. Efficient T cell activation is critical for vaccination purposes, while the inhibition o
Autor:
D E, Speiser, D, Valmori, D, Rimoldi, M J, Pittet, D, Liénard, V, Cerundolo, H R, MacDonald, J C, Cerottini, P, Romero
Publikováno v:
European journal of immunology. 29(6)
In humans, NK receptors are expressed by natural killer cells and some T cells, the latter of which are preferentially alphabetaTCR+ CD8+ cytolytic T lymphocytes (CTL). In this study we analyzed the expression of nine NK receptors (p58.1, p58.2, p70,
Publikováno v:
European journal of immunology. 28(10)
Understanding the parameters involved in T cell activation has been complicated by the discovery of partial T cell agonists. Altered peptide ligands (APL) have recently shown that different subsets of T cell responses can be selectively activated by